Digital Neuro Biomarkers Market to reach USD 4592.14 million by 2032, growing at a CAGR of 25.96%
The market for digital neuro biomarkers is growing exponentially as a result of increasing neurological disorders, advancements in technology, and the growing demand for personalized healthcare solutions. These are essentially used for the diagnosis, monitoring, and tracking of the progression of various neurological conditions such as Parkinson\'s disease, Alzheimer\'s disease, multiple sclerosis, and epilepsy. Furthermore, real-time data as well as deeper insights into a patient\'s health condition are fuelling the adoption of digital neuro biomarkers across health care settings.